Skip to main content

Table 1 The comparison of baseline characteristics, conventional MRI features, and CD8 + T cells in recurrence and non-recurrence meningiomas[ case (%)]

From: MRI features and tumor-infiltrating CD8 + T cells-based nomogram for predicting meningioma recurrence risk

Parameters

Recurrence(n = 30)

Non-recurrence(n = 72)

Statistical values

p-value

Age

48.03 ± 14.31

51.99 ± 13.24

1.342

0.183

Sex

  

1.077

0.299

 Female

19 (63.3%)

53 (73.6%)

  

 Male

11 (36.7%)

19 (26.4%)

  

Location

  

0.413

0.521

 Skull base

8 (26.7%)

15 (20.8%)

  

 Non skull base

22 (73.3%)

57 ( 79.2%)

  

Necrosis

  

0.596

0.440

 Yes

15 (50.0%)

30 (41.7%)

  

 No

15 (50.0%)

42 (58.3%)

  

Grade

  

13.909

0.001

 WHO 1

12 (40.0%)

54 (75.0%)

  

 WHO 2

16 (53.3%)

18 (25.0%)

  

 WHO 3

2 (6.7%)

0 (0.0%)

  

Enhancement

  

4.870

0.027

 Homogeneous

6 (20.0%)

31 (43.1%)

  

 Inhomogeneous

24 (80.0%)

41 (56.9%)

  

Tumor shape

  

2.857

0.091

 Round

12 (40.0%)

42 (58.3%)

  

 Lobulation

18 (60.0%)

30 ( 41.7%)

  

 Tumor diameter

4.24 ± 1.20

4.73 ± 1.27

1.798

0.075

 Tumor volume

208.97 ± 253.11*

269.69 ± 367.00*

−1.447

0.148

 Edema diameter

0.00 ± 3.15*

1.55 ± 3.80*

−0.912

0.362

 Edema volume

48.52 ± 11.62*

56.22 ± 12.11*

−1.013

0.311

 Edema index

1.00 ± 1.80*

1.00 ± 0.81*

−0.530

0.596

 Ki−67 PI

5.00 ± 17.00*

3.00 ± 5.75*

−2.621

0.009

Simpson grade

  

2.982

0.394

 Simpson I

4 (13.3%)

17 (23.6%)

  

 Simpson II

6 (20.0%)

19 (26.4%)

  

 Simpson III

11 (36.7%)

23 (31.9%)

  

 Simpson IV

9 (30.0%)

13 (18.1%)

  

Postoperative therapy

  

1.772

0.183

 Yes

4 (13.3%)

4 (5.6%)

  

 No

26 (86.7%)

68 (94.4%)

  

CD8 + T cells (%)

0.06 ± 0.13*

0.17 ± 0.25*

−3.382

0.001

  1. Continuous variables with a normal distribution are presented as mean ± standard deviation; non-normal variables are reported as median ± interquartile; number of cases (percentage) for categorical data
  2. * non-normal distribution